LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.62
(-2.31%)
CNY 18.62
(-2.31%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.77 Billion CNY | -10.27% |
| 2022 | 6.43 Billion CNY | 27.53% |
| 2021 | 5.04 Billion CNY | 12.62% |
| 2020 | 4.47 Billion CNY | 14.3% |
| 2019 | 3.91 Billion CNY | 17.49% |
| 2018 | 3.33 Billion CNY | 25.9% |
| 2017 | 2.64 Billion CNY | 20.5% |
| 2016 | 2.19 Billion CNY | 29.24% |
| 2015 | 1.7 Billion CNY | 16.57% |
| 2014 | 1.45 Billion CNY | 22.3% |
| 2013 | 1.19 Billion CNY | 19.42% |
| 2012 | 998.93 Million CNY | 19.47% |
| 2011 | 836.17 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.4 Billion CNY | -27.29% |
| 2024 Q1 | 1.93 Billion CNY | 15.2% |
| 2024 Q3 | 1.74 Billion CNY | 24.08% |
| 2023 Q2 | 1.74 Billion CNY | -2.95% |
| 2023 FY | 5.77 Billion CNY | -10.27% |
| 2023 Q4 | 1.67 Billion CNY | 0.05% |
| 2023 Q3 | 1.67 Billion CNY | -3.79% |
| 2023 Q1 | 1.79 Billion CNY | -6.22% |
| 2022 Q1 | 1.42 Billion CNY | 8.11% |
| 2022 FY | 6.43 Billion CNY | 27.53% |
| 2022 Q4 | 1.91 Billion CNY | 21.47% |
| 2022 Q3 | 1.57 Billion CNY | 3.69% |
| 2022 Q2 | 1.51 Billion CNY | 6.97% |
| 2021 Q4 | 1.31 Billion CNY | 6.3% |
| 2021 Q2 | 1.27 Billion CNY | 4.5% |
| 2021 Q1 | 1.21 Billion CNY | 2.48% |
| 2021 Q3 | 1.23 Billion CNY | -2.91% |
| 2021 FY | 5.04 Billion CNY | 12.62% |
| 2020 Q3 | 1.12 Billion CNY | 4.94% |
| 2020 Q1 | 1.08 Billion CNY | 0.43% |
| 2020 Q2 | 1.07 Billion CNY | -0.98% |
| 2020 FY | 4.47 Billion CNY | 14.3% |
| 2020 Q4 | 1.18 Billion CNY | 5.41% |
| 2019 Q3 | 948.83 Million CNY | -0.65% |
| 2019 Q2 | 955.06 Million CNY | 2.39% |
| 2019 Q1 | 932.81 Million CNY | 0.73% |
| 2019 FY | 3.91 Billion CNY | 17.49% |
| 2019 Q4 | 1.08 Billion CNY | 13.92% |
| 2018 Q3 | 817.34 Million CNY | 3.49% |
| 2018 FY | 3.33 Billion CNY | 25.9% |
| 2018 Q4 | 926.08 Million CNY | 13.3% |
| 2018 Q1 | 801.34 Million CNY | 6.58% |
| 2018 Q2 | 789.74 Million CNY | -1.45% |
| 2017 Q1 | 630.07 Million CNY | -0.75% |
| 2017 FY | 2.64 Billion CNY | 20.5% |
| 2017 Q4 | 751.84 Million CNY | 14.78% |
| 2017 Q3 | 655.01 Million CNY | 7.1% |
| 2017 Q2 | 611.62 Million CNY | -2.93% |
| 2016 Q2 | 520.82 Million CNY | 6.58% |
| 2016 Q4 | 634.81 Million CNY | 14.67% |
| 2016 FY | 2.19 Billion CNY | 29.24% |
| 2016 Q1 | 488.66 Million CNY | -1.15% |
| 2016 Q3 | 553.6 Million CNY | 6.3% |
| 2015 Q4 | 494.35 Million CNY | 20.58% |
| 2015 Q2 | 398.24 Million CNY | 0.06% |
| 2015 Q1 | 397.99 Million CNY | -6.86% |
| 2015 Q3 | 409.99 Million CNY | 2.95% |
| 2015 FY | 1.7 Billion CNY | 16.57% |
| 2014 Q2 | 339.05 Million CNY | 0.36% |
| 2014 Q4 | 427.29 Million CNY | 20.46% |
| 2014 Q3 | 354.71 Million CNY | 4.62% |
| 2014 FY | 1.45 Billion CNY | 22.3% |
| 2014 Q1 | 337.82 Million CNY | 0.0% |
| 2013 FY | 1.19 Billion CNY | 19.42% |
| 2012 FY | 998.93 Million CNY | 19.47% |
| 2011 FY | 836.17 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 347.55 Million CNY | -1560.465% |
| Jointown Pharmaceutical Group Co., Ltd | 11.1 Billion CNY | 48.043% |
| Yifeng Pharmacy Chain Co., Ltd. | 8.63 Billion CNY | 33.133% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 3.25 Billion CNY | -77.138% |